Risk / benefit ratio cyclosporin A(Sandimmun) in psoriasis
Treść karty:MIHATSCH M.J. [red.] 300,728 Risk / benefit ratio cyclosporin A(Sandimmun) in psoriasis : Proceedings of an International consensus meeting sponsored by Sandoz Pharma Loja, Granada, Spain, 26-28 February 1990 / guest ed-s M.J. Mihatsch [et al.] : Prepared by CCT presentations on behalf of Sandoz Pharma AG. - Oxford : Blackwell Scientific Publ,., [1990]. - V, [1], 150 s. : il., wykr. ; 25 (British Journal of Dermatology, ISSN 0366-077X ; vol. 122, suppl. 36)